Jump to main content
Jump to site search

Issue 4, 2015
Previous Article Next Article

Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent α1 and 5-HT1A receptor ligand: an in vitro and computational study

Author affiliations

Abstract

In this paper, the enantiomers of (±)-1, previously studied as α1 and 5-HT1A ligands, were prepared both by resolution of the racemate and asymmetric synthesis. The enantiomeric purity and absolute configuration were determined by means of HPLC and polarimetric analysis. Enantiomers were evaluated for in vitro 5-HT1A and α1 receptor affinity by binding and functional assays. Results indicate that the two enantiomers are almost equally potent at 5-HT1A and α1 receptor systems and, contrary to WB 4101, the stereoselectivity is poor. As further support to these experimental findings, molecular docking studies on the two enantiomers of (±)-1 have been performed and a comparison with those obtained for 5-HT1A potent agonist (R)-flesinoxan and α1d antagonist (S)-WB 4101 has been drawn.

Graphical abstract: Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent α1 and 5-HT1A receptor ligand: an in vitro and computational study

Back to tab navigation

Publication details

The article was received on 25 Oct 2014, accepted on 19 Dec 2014 and first published on 23 Dec 2014


Article type: Concise Article
DOI: 10.1039/C4MD00484A
Author version
available:
Download author version (PDF)
Citation: Med. Chem. Commun., 2015,6, 677-690
  •   Request permissions

    Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent α1 and 5-HT1A receptor ligand: an in vitro and computational study

    S. Franchini, A. Baraldi, C. Sorbi, F. Pellati, E. Cichero, U. M. Battisti, P. Angeli, A. Cilia and L. Brasili, Med. Chem. Commun., 2015, 6, 677
    DOI: 10.1039/C4MD00484A

Search articles by author

Spotlight

Advertisements